AGENUS INC Increase (Decrease) in Inventories
AGENUS INC (AGEN) reported Increase (Decrease) in Inventories of -$55.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2022-03-01
- AGENUS INC increase (decrease) in inventories for the quarter ending 2018-12-31 was $0.00.
- AGENUS INC increase (decrease) in inventories for the quarter ending 2018-09-30 was $0.00.
- AGENUS INC increase (decrease) in inventories for the quarter ending 2018-06-30 was -$7.00K.
- AGENUS INC increase (decrease) in inventories for the quarter ending 2018-03-31 was -$17.00K.
- AGENUS INC increase (decrease) in inventories for fiscal 2019 was -$55.00K.
- AGENUS INC increase (decrease) in inventories for fiscal 2018 was -$24.00K.
- AGENUS INC increase (decrease) in inventories for fiscal 2017 was -$9.00K.
- AGENUS INC increase (decrease) in inventories for fiscal 2015 was -$7.50K, a 107.84% decline from fiscal 2014.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | -$55.00K 10-K · filed 2022-03-01 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | -$7.00K derived: sum of 3 quarters · filed 2021-03-16 | -$24.00K 10-K · filed 2021-03-16 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$7.00K derived: sum of 2 quarters · filed 2019-11-07 | -$24.00K 10-Q · filed 2019-11-07 | -$25.04K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$24.00K 10-Q · filed 2019-08-09 | -$25.04K derived: sum of 3 quarters · filed 2020-03-16 | |||||
| 2018-03-31 | -$17.00K 10-Q · filed 2019-05-10 | -$17.25K 10-Q · filed 2018-05-10 | -$18.04K derived: sum of 2 quarters · filed 2020-03-16 | |||||
| 2017-12-31 | -$1.04K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$9.00K 10-K · filed 2020-03-16 | -$8.71K 10-K · filed 2018-03-16 | |||||
| 2017-09-30 | -$7.96K 10-Q · filed 2018-11-07 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | -$7.50K 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | -$7.50K 10-Q · filed 2016-11-09 | -$7.50K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$7.50K 10-Q · filed 2016-08-04 | -$7.50K derived: sum of 3 quarters · filed 2017-03-16 | -$7.50K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$7.50K 10-Q · filed 2016-05-09 | -$7.50K derived: sum of 2 quarters · filed 2017-03-16 | -$7.50K derived: sum of 3 quarters · filed 2017-03-16 | $88.20K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $95.70K derived: sum of 3 quarters · filed 2017-03-16 | $95.70K 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $95.70K derived: sum of 2 quarters · filed 2015-11-04 | $95.70K 10-Q · filed 2015-11-04 | $92.43K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $95.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $95.70K 10-Q · filed 2015-08-03 | $92.43K derived: sum of 3 quarters · filed 2016-03-15 | $91.68K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-01 | -$3.27K derived: sum of 2 quarters · filed 2016-03-15 | -$4.02K derived: sum of 3 quarters · filed 2016-03-15 | -$16.02K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | -$3.27K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$4.02K derived: sum of 2 quarters · filed 2016-03-15 | -$16.02K derived: sum of 3 quarters · filed 2016-03-15 | -$16.02K 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | -$750.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$12.75K derived: sum of 2 quarters · filed 2014-10-31 | -$12.75K 10-Q · filed 2014-10-31 | $12.75K 10-Q · filed 2013-11-08 | -$20.85K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$12.00K 10-Q · filed 2014-08-01 | $12.00K 10-Q · filed 2013-08-09 | -$20.10K derived: sum of 3 quarters · filed 2015-03-16 | -$17.55K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | -$8.10K derived: sum of 2 quarters · filed 2015-03-16 | -$5.55K derived: sum of 3 quarters · filed 2015-03-16 | -$5.55K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | -$8.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$5.55K derived: sum of 2 quarters · filed 2015-03-16 | -$5.55K derived: sum of 3 quarters · filed 2015-03-16 | -$4.05K 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $2.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $2.55K derived: sum of 2 quarters · filed 2013-11-08 | $4.05K 10-Q · filed 2013-11-08 | -$4.05K 10-Q · filed 2012-11-07 | -$2.31K derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.50K 10-Q · filed 2013-08-09 | -$1.50K 10-Q · filed 2012-08-08 | -$4.86K derived: sum of 3 quarters · filed 2014-03-07 | -$4.86K derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-03-31 | $1.50K 10-Q · filed 2013-05-10 | -$1.50K 10-Q · filed 2012-05-09 | -$4.86K derived: sum of 2 quarters · filed 2014-03-07 | -$4.86K derived: sum of 3 quarters · filed 2014-03-07 | -$4.86K derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2011-12-31 | -$6.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$6.36K derived: sum of 2 quarters · filed 2014-03-07 | -$6.36K derived: sum of 3 quarters · filed 2014-03-07 | -$6.36K 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | $0.00 derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $0.00 10-Q · filed 2011-08-05 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | -$64.40K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | -$64.40K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$64.40K derived: sum of 2 quarters · filed 2013-03-18 | -$297.60K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | -$64.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$297.60K 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$233.20K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $97.66K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |